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Since the chemical synthesis of acetylcholine (ACh) was described
toward the close of the last century,'6 an extensive literature has developed
in regard to its pharmacologic activity, and considerable evidence has been
gathered to implicate it in some of the fundamental processes of the
nervous system. Information concerning this substance appears to have
been gained at first through investigative effort directed toward its general
physiological properties as mediated through the autonomic nervous sys-
tem. As a sequel to this phase in experimental approach, attention was
focused next upon its possible r6le in peripheral nerve physiology, and,
more recently, rather intense interest has developed as to its place in meta-
bolic processes of the brain. Certain hypotheses have been advanced regard-
ing its participation in the integral physiology of the central nervous
system, and some of the manifestations of disturbed physiology as reflected
in clinical problems such as epilepsy and head injury, for example, have
been attributed to derangement of this aspect of metabolic function. It seems
appropriate, therefore, to review the pertinent contributions in this field
which serve as foundations upon which current concepts are based.
An active interest in the choline derivatives already existed at the time
that Nothnagel (1894) successfully synthesized ACh,' by reason of the
contemporary pharmacological studies devoted to muscarine and neurine
with which there appeared to be close chemical relationship. Mott and
Halliburton'7 drew attention to the presence of choline in the cerebrospinal
fluid of patients with epileptic manifestations secondary to destructive
processes of the brain (general paralysis); however, this remarkable cor-
relation was not entirely appreciated at the time. In the course of their
experimental studies, they recognized as well that atropine prevented the
fall in blood pressure which ordinarily followed injection of choline, and
they thereby provided a groundwork for observations on choline-atropine
antagonism. It was during the same period that Reid Hunt' in 1901 iso-
lated a blood pressure lowering principle in aqueous extract from su-
prarenal tissue, sympathetic ganglia, and brain, and suggested that this
substance might be an "ester-like body containing choline in its molecule."
In a later communication, Hunt and TaveauM discussed the marked potency
of the acetylated form compared with choline and its other derivatives in
depressing blood pressure and respiration. Shortly thereafter, Frank and
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Isaac' in 1909 and Meyer' in 1912 proposed general pharmacological
parallelisms between (i) choline derivatives and the parasympathetic
nervous system, and (ii) adrenalin and the sympathetic nervous system.
However, formulation of a sound basis for pharmacological study of the
autonomic nervous system may be properly attributed to Langley,"' who
extended and developed the pioneer efforts of Gaskell' in the physiology
of the "involuntary" nervous system. An appreciation of the neurochemical
antagonisms existing within this system is set down in Langley's mono-
graph, Autonomic nervous system. Much of the available information con-
cerning the activity of the parasympathetic component up to this time,
however, had been derived from observations on the effects induced by
pilocarpine.
Largely through the encouragement of Dale, the chemical identification
of ACh as an active principle of ergot was established by Ewins`9'9 in 1914.
The comparative biological actions of the choline derivatives, esters, ethers,
and ACh were investigated extensively by Dale1' who reported on their
properties in detail.
ACh and electrocortical activity
Some historically important observations concerning the action of para-
sympathetic drugs have been made by employing the intraventricular route
of administration. While studying the intraventricular effects of pituitrin,
Cushing"8 noted that its action strikingly resembled that of pilocarpine.
When pilocarpine was injected intraventricularly, the effects were much
greater than those seen when the subcutaneous route was employed; body
temperature fell appreciably, and sweating, salivation, retching, and vomit-
ing were extremely severe at times. The mechanism was believed to involve
central autonomic stimulation, being predominantly parasympathetic in
character. Atropinization by the subcutaneous route or by intraventricular
instillation counteracted these effects.
Intraventricular injection of ACh in unanesthetized cats'3'
"" resulted
almost invariably in temporary cessation of respiration followed by a sleep-
like state lasting several hours. Irregularities of the heart, similar to those
seen after stimulation of the central end of the vagus nerve, were observed
as well.' The intraventricular route was also employed in clinical studies,
where onset of nausea, sweating, and often vomiting were observed.' Other
early observations on the central nervous system effects of ACh were made
using the encephale isole preparation in cats." 8 In these instances, carotid
injection of ACh produced increased frequency of the "Berger waves"
emanatingfrom the cortex, and electroencephalographic patterns resembling
those which accompany the awakening reaction were noted.
With the development of electroencephalographic techniques, studies
concerning the neuropharmacological action of acetylcholine were extended
to observations on the cerebral cortex. SjdstrandTM found that changes in
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electrical potentials induced by strychninization of rabbit cortex were en-
hanced if ACh or eserine was applied before, simultaneously with, or sub-
sequent to strychninization. Miller and his co-workers"' noted that the
topical application of ACh to eserinized cortex was attended by spike dis-
charges in the electrocorticogram and occasionally by motor responses;
atropinization of these animals prevented both the electrographic and motor
phenomena.
Chatfield and Dempsey"2 observed characteristic changes in the electro-
corticogram of cats when various areas of eserinized cortex (somesthetic,
auditory, and motor cortex) were treated with 1 per cent ACh. These
changes consisted of increased spontaneous electrocortical activity, the
appearance of 5 to 10 per second spike discharges and, later 20 to 30 per
second low amplitude spikes which spread to certain other cortical areas.
Atropinization was found to abolish interval spike potentials but not the
ACh bursts per se. Brenner and Merritt7 found, however, that topical ACh
in concentrations of 2.5 to 10 per cent was followed by spike discharges
without resort to eserine, and that the electrographic manifestations were
-not inhibited by atropine, 1 mg. per kg. They suggested that the effect of
ACh and other choline derivatives upon the cerebral cortex is comparable
to the action of ACh upon sympathetic ganglia and at the skeletal myo-
neural junction. Forster' established the relationship of focal motor phe-
nomena of the seizure discharge with ACh-induced spike discharges in the
electrocorticogram.
Kristiansen and Courtois,' by demonstrating that isolated cerebral cortex
responds with rhythmic spike discharges after topical application of ACh,
have excluded thalamo-cortical connections as essential for the synchroniza-
tion of neuronal activity which results in spike discharges. Beckett anld
Gellhorn' observed that when ACh was applied to "suppressor areas" of
cat and macaque cortex, local suppression of electrocortical activity oc-
curred and likewise loss of spontaneous or electrically induced movements.
They found that ACh augmented action potentials evoked by peripheral
stimulation and recorded from somesthetic receiving areas; cholinesterase
(ChE) applied topically to cortex had the opposite effect. In a later study,
Hyde, Beckett, and Gellhorn' reported that the effect of eserine, whether
given intravenously or applied topically to the cerebral cortex, potentiated
the activity of a wide group of chemically different convulsant agents and
they suggested that ACh might be employed for activation of the electro-
encephalogram. However, Kaufman, Marshall, and Walker,' in clinical
studies on activation of the electroencephalogram (EEG), failed to find
any significant alteration in the pattern of the EEG after intravenous
administration of ACh.
Jacksonian seizures have been produced in unanesthetized rabbits by
topical application of ACh to the masticatory cortex. Eserinization of the
cortex enhanced the convulsive manifestations, whereas intravenous atro-
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pine abolished these seizure discharges.! Marrazzi and Hart"2 observed that
when ACh is injected into the carotid artery, potentiation of the response
of the visual cortex to optic nerve stimulation occurs. Di-isopropyl-fluoro-
phosphate (DFP) also enhanced these responses while atropine diminished
them.'
Cholinergic areas of the central nervous systenm
Methods of determining choline acetylase (ChA) activity have made
possible the investigation of the propensity of different regions of the central
nervous system to synthesize ACh.' Based upon this method of assay,
nuclear masses and tracts of the nervous system have been classified as
belonging predominantly to either cholinergic or non-cholinergic systems.22
The topographically distinct areas which display high levels of ChA activity
(cholinergic group) include the anterior horn cells, anterior roots, and the
motor nuclei of the cranial nerves. The pyramidal tracts uniformly show
low ChA activity. The motor cortex appears to have an intermediate level
of ChA activity, the inference being that cholinergic fibers converge upon
the pyramidal cell population which is per se non-cholinergic. The fact
that topical application of eserine and ACh to motor cortex causes discharge
of impulses in the pyramidal tracts would appear to strengthen the view
that cholinergic fibers may fire the non-cholinergic neurones of the pyramidal
system.
This general pattern of organization, namely, a succession of alternating
cholinergic and non-cholinergic neuronal aggregates, has also been demon-
strated by ChA determinations using the ascending sensory pathways of the
spinal cord. The posterior roots and the tracts of the dorsal columns of
the cord have been shown to be non-cholinergic, while the nuclei gracilis
and cuneatus are cholinergic. Generally, the second order ascending fibers
(lateral lemniscus and spinocerebellar tracts) show intermediate values
of ChA activity, whereas the third order neurone of the afferent path seems
to be non-cholinergic. The supraoptic nucleus possesses high ChA activity.
This finding is consistent with its ease of excitation by ACh or DFP."
Similarly, the caudate nucleus, red nucleus, and hippocampal formation
show moderately high ChA values. An alternating system of cholinergic
and non-cholinergic neurones has been shown to exist in the cerebellum and
its projections as well as within relay pathways of the visual system.
Species variations in ChA activity suggests that an element of caution be
taken in the interpretation and acceptance of strict categorization of different
chemical neuronal systems within the central nervous system. Nevertheless,
additional indirect evidence for the presence of cholinergic and non-choliner-
gic neuronal systems within the cerebral cortex seems to be the selective
inhibition of ACh-induced cortical spike discharges, by intravenous atropine
sulphate and adenine nucleotides in doses which are completely ineffective
in diminishing strychnine-induced spikes or in altering the level of
spontaneous electrocortical activity (see below).'
38ACETYLCHOLINE AND CNS
ACh-atropine antagonismn within the central nervous system
The pharmacological antagonism of atropine to the muscarinic effects of
ACh is well known."4 Atropinization of an animal will prevent the develop-
ment of spike potentials which usually follows the topical application of
ACh to cerebral cortex.'6 Intraventricular injection of atropine in conjunc-
tion with ACh does not result in spike discharges usually seen when ACh
is given alone.' However, others have found that atropinization (1 mg./kg.)
failed to counteract the effects of ACh applied topically or injected into the
subarachnoid cisterns, and they have concluded that its action upon cere-
bral cortex more closely resembled that upon sympathetic ganglia and
parasympathetic end organs.7 Other experimental observations indicate
that this atropinizing dose is relatively ineffecive for ACh antagonism and
that greater doses (2-5 mg./kg.) are necessary for the inhibition of ACh-
induced spike discharges without necessarily causing depression of spoIl-
taneous electrocortical activity.'
The clinical studies of Williams' demonstrate that atropine inhibits the
frequency or ease of induction of petit mal attacks precipitated by the
injection of eserine or ACh in patients with petit mal epilepsy. Another
interesting phenomenon, although by no means completely understood, is
the clinical and subjective improvement which occurs in the Parkinsonian
syndrome following the use of atropine or related compounds. The site of
the pathological process in this disorder is usually located in the basal
ganglia which have been shown to be predominantly cholinergic." It seems
reasonable to speculate on the possibility of a derangement of ACh meta-
bolism as the underlying mechanism responsible for the clinical manifesta-
tions attending this syndrome. The amelioration which occurs with atropine
may be related to ACh antagonism at this or other neural levels.
In recent years, studies of metabolic changes in cerebral tissue following
experimental head injuries have disclosed significant alterations of funda-
mental neurochemical mechanisms.' Traumatized areas of cortex show ap-
preciable increases in lactic acid and inorganic phosphate content, whereas
phosphocreatine and ATP levels are decreased. The adenine nucleotides,
of which ATP is the most potent member, comprise the "adenylic acid
system" which serves as the chief regulatory mechanism of oxidative glu-
cose metabolism. Bornstein' has clearly demonstrated that free ACh, which
is not present normally in the cerebrospinal fluid (CSF), appears in signifi-
cant amounts following experimental cerebral trauma.
There appears to be a strong correlation between the amount of ACh
which appears in the CSF, and behavioral and EEG changes following ex-
perimental brain concussion. That the elaboration of free ACh following
cerebral trauma is responsible for the acute paralytic state and the later
excitatory phenomena may be inferred from these experimental data.
Bornstein' found that atropine abolished the stupor and abnormal EEG
patterns seen as sequelae of experimental brain trauma. Atropine relieved
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behavioral and EEG changes produced by intracisternal injection of ACh.
These alterations closely simulated the manifestations following experi-
mental head injuries described above. Tower and McEachern observed
low ChE activity and liberation of free ACh in the CSF of patients with
head injuries' and also in epileptics.' With clinical recovery, these indices
of chemical change reverted to normal. Further, there seemed to be close
correlation between ChE activity, ACh level of the CSF, degree of EEG
abnormality, and the clinical state of the patient. Ward' employed atropine
in the treatment of patients with severe closed head injuries having ap-
preciable cerebral damage as evidenced by depth of coma, focal neurologi-
cal signs, and grossly bloody CSF. The rationale of treatment was based
on the aforementioned experimental evidence' 62, that the chemical changes
associated with anatomical damage can be vitiated by anticholinergic agents.
Definite improvement was seen in the state of consciousness in the patients
so treated.
Anticholinesterases
The anticholinesterases may produce states of increased electrocortical
excitability comparable in many ways to those seen following topical
application of ACh.'9 Although it has been generally assumed that the
mechanism of action is mediated through the accumulation of undestroyed
ACh, this is by no means certain.'2 However, whether the anticholinesterases
excite neuronal elements directly by reason of their chemical structure, or
cause inhibition of ChE by some chemical union with this substance, is still
a matter of speculation. The latter mechanism probably is involved in the
action of eserine, for, when this substance is applied directly to cerebral
cortex, rarely is the electrocortical pattern so affected as to result in spike
discharges. Similar to eserine are the mechanisms of action of DFP and
tetra-ethylprophosphate (TEP) ;" however, their combination with ChE
appears to be relatively irreversible.6' These agents also affect cell respira-
tory functions of brain tissue, and may possibly exert their effects secondar-
ily through a disturbance in cerebral oxidative metabolism.8'
Propagation of the nerve impulse in isolated nerve preparations requires
the integrity of certain metabolic processes; e.g., the phosphorylation
cycle, the synthesis and breakdown of ACh by ChA and ChE. The experi-
mental findings of Nachmansohn and Feld' indicate that DFP acts rela-
tively slowly but progressively in inhibiting ChE, which makes determina-
tions of ChE activity over regular intervals possible. Exposure of the stellar
or proximal fin nerve on the giant axon of the squid to 0.01 molar solution
of eserine has been shown to abolish the action potential, but this effect
is reversible inasmuch as the state of excitability may be restored by bath-
ing the nerve preparation in sea water.'0 However, under similar experi-
mental conditions, DFP abolished conduction of the nerve impulse when
the ChE was reduced to 3 per cent or less of the control level.9 These
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observations show further the integral role of ACh and ChE in the
mechanism of nerve conduction. The excitability of cortical neurones is
diminished by ChE and augumented by eserine; topical application of
eserine and ACh to cortical suppressor areas, however, may produce a
local suppression of spontaneous electrocortical activity.2
EEG changes similar to those seen clinically in status epilepticus have
been observed following injection of DFP into the common carotid artery
of rabbits. These changes were associated with markedly diminished ChE
activity of the cortex."' The normal electrocortical pattern could be re-
established in these animals by atropinization. The level of ChE following
the administration of DFP appears to be inversely proportional to the
varying degrees of abnormality in the electrocorticogram. According to
Nachmansohn and Feld,w abnormal EEG patterns were produced only
after an appreciable decrease in the level of ChE activity occurred and,
therefore, there seems to be a wide safety margin in the maintenance of
normal neuronal excitability. Complete inactivation of ChE, however, is
apparently incompatible with life.
The injection of DFP into the supraoptic nucleus results in a decrease
in urine flow in dogs.'7 The mechanism is presumably one of prolonged
stimulation of this nucleus by the accumulation of ACh, which results in
an increased liberation of antidiuretic hormone.
DFP has received extensive investigation in clinical medicine."' This
agent has been employed in the treatment of abdominal distention in con-
junction with neostigmine and appears to potentiate the effect of neostig-
mine in relieving this condition. However, patients who received this treat-
ment experienced untoward symptoms consisting of excessive dreaming,
nightmares, paresthesias and delirium, which were found to be diminished
largely by the administration of atropine. Clinical investigations have re-
vealed that DFP causes an increase in electrocortical activity, increases
in the predominant cerebral rhythms, paroxysmal irregularities of rhythm,
and occasionally high voltage slow activity most marked in frontal leads.
Atropine was observed to have a beneficial effect in approximately 50
per cent of their patients who showed abnormal EEG findings after
administration of DFP.'9
Although the mechanism through which DFP exerts its effects upon the
central nervous system is not entirely clear, the indirect evidence of atro-
pine antagonism suggests that perhaps its action is intimately related to
altered ACh metabolism.
The role of the adenine nucleotides in central nervous system metabolismn
It has been shown that ATP is necessary for the in vitro synthesis of
ACh, and that the energy derived from the splitting of the organic phos-
phate linkages of ATP is apparently utilized in this synthesis.5' The ob-
servations of Stone, et al.62 on chemical changes following experimental
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head injuries disclosed that areas of contused brain have increased lactic
acid and inorganic phosphate levels, while a decrease in phosphocreatine
and ATP content consistently occurs. The relationship of adenine nu-
cleotides (adenylic acid system) to the convulsant action of ACh has come
under study recently.-' ATP and other adenine derivatives applied topi-
cally or injected intravenously inhibit characteristic ACh-induced high
voltage electrocortical discharges."' These findings suggest that adenine
derivatives may have a place in the treatment of certain clinical disorders,
i.e., seizure disturbances and head injuries.57 The mechanism of this inhibi-
tion is not known. However, it is possible that excessive concentration of
ACh may cause depletion or retard formation of ATP, allowing the neuronal
pool to respond to ACh by synchronous discharge. Increasing the ATP
concentration either by topical application or intravenous administration
may then restore the chemical equilibrium. There is at present, however,
no proof for this proposed mechanism.
The ACh content of brain has been shown to vary with its physiological
state; it is elevated during sleep and anesthesia, whereas decreased levels
occur during emotional excitement, convulsions, and following electrical
stimulation of the brain.' The destruction and resynthesis of ACh in vivo
have been found to be rapidly reversible. Attention has been directed also
to the findings that during anesthesia (when ACh synthesis would be ex-
pected to be minimal), brain lactic acid level is low and the phosphocreatine
level is high. During electrical stimulation or convulsions the relationships
between lactic acid and phosphocreatine are reversed, possibly indicating
an increase in ACh synthesis. It was felt that the increased frequency of
seizures and EEG changes seen clinically in epileptic patients during the
early stages of anesthesia and sleep may be due to high ACh levels in the
brain resulting from minimal utilization of ACh during these states. Al-
though the neuronal excitability under these conditions is decreased, ACh
may accumulate to a level which will stimulate and discharge neuronal ag-
gregates, whereas deeper anesthesia may interfere with metabolic processes
generally and thereby prevent excessive accumulation of ACh.
The inferences gained from observations on nucleotide and ACh levels,
and their correlation with physiological activity of the cortex, aid in some
measure in evaluating the role of ACh in the central nervous system.
Other mediators in the central nervous system
Until recent years, the role of ACh has been preeminent in discussions
of the chemical theory of conduction and synaptic transmission. Then, in
1948, Hellauer and Umrath"' postulated another as yet unidentified
agent as being involved in synaptic transmission and as producing vaso-
dilatation, including that seen on antidromic stimulation. They concluded
that this "ferment" is subject to enzymatic destruction and that strychnine
inhibits this process. Strychnine-induced electrocortical discharges are
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dissimilar to those caused by ACh: the latter produces bursts of high
amplitude negative spikes occurring usually at a frequency of about 10-15
per second. Strychnine spikes are of somewhat higher amplitude, custom-
arily accompanied by an initial positive deflection, and recur singularly
usually every 5 to 10 seconds, although the frequency of firing is variable.
The underlying mechanism of this firing process would seem to be different,
since the action of atropine and adenine nucleotides on spike discharges
induced by these two agents is quite dissimilar.
Observations on the effect of ACh on the cerebellar cortex have disclosed
that ACh is relatively ineffective in inducing spike discharges.' Since high
amplitude spike discharges are presumably the result of synchronous firing
of neuronal groups, the closely connected cells of the cerebellar cortex
would seem to provide an ideal location for such synchrony to occur. The
inefficacy of ACh applied to the cerebellar cortex would seem to refute
either the theory of spike production or the theory of universality of ACh
transmission; but other findings such as the variability of effect of ACh
on different areas of cortex seem to support the view that there may be
more than one chemical mediator responsible for synaptic transmission.
Mention might also be made of the variable clinical and EEG patterns
observed in cryptogenic epilepsy, and of the relative specificity of drugs
used in their treatment-tridione in petit mal, phenurone in psychomotor
seizures, and dilantin and phenobarbital in grand mal. This near thera-
peutic specificity may be indicative of derangements in different chemical
mechanisms involved in synaptic transmission.
Chemical theory of conduction and transmlission
In 1945, Feldberg' in assessing the r6le of ACh in the CNS, outlined
its status as a "central synaptic transmittor" of nerve impulses. He stated
that the "presence of ACh and ChE in central nervous tissue, the ability
of such tissue to synthesize ACh and to release it under certain conditions,
the central effects of ACh and of eserine, all provide strong evidence in
favor of the theory that the transmission across a number of synapses in
the central pathway of autonomic and motor neurones occurs through the
mediation of ACh." Some of the objections to the acceptance of this thesis
which regards ACh as the universal central transmittor were also con-
sidered. In the ascending phylogenetic scale the more developed brains
have appeared to become less dependent upon ACh metabolism in that the
ability to synthesize ACh, the concentration of ChE, and the ACh content
of the nervous tissue are all decreased. The finding of cholinergic and non-
cholinergic neurones and tracts, and a low ACh content in cerebellar cortex
which is rich in synaptic relationships, throws some doubt concerning the
universality of ACh in central transmission and conduction. However,
important evidence against the alternative theory which considers the action
current as the synaptic transmittor was cited by Feldberg,2' as follows:
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the inability of the impulse to cross the synapse in sympathetic ganglia
when the ACh content of the nerve had been markedly reduced and the
ability of the nerve to synthesize ACh had been lost, and the observation
that only cholinergic fibers are able to make functional connection with
sympathetic ganglia in regeneration experiments.41
Nachmansohn in 1946,49 in regarding ACh as essential in conduction and
transmission, based his theory upon the following evidence. From observa-
tions on the electric eel, the concentration of ChE in nerve tissue was
found to be high enough to permit an enzymatic process whose time re-
lations are commensurate with electric manifestations of nerve impulses.'8'
The localization of ChE at those neuronal surfaces which present bio-
electrical phenomena contrasts remarkably with the localization of other
enzymes in the body.' The formation of ACh by ChA has been found to
occur at a rapid rate. A direct proportionality between ChE activity and
the voltage of current exists in the electric organ of Electophorus electricus,'2
and it is generally agreed that the high energy bonds of ATP provide the
energy necessary for ACh synthesis."9 Finally, the ability of anticholine-
sterases to diminish and, in high concentrations, to abolish the action
potential in nerve9"0 has been shown, and this adds to the necessity of an
intact ACh metabolic process for impulse conduction. WhitteridgeT feels
that the action of ACh in the central nervous system is mainly concerned
with the "facilitation ofrepetitive activity, particularly in the interneurones,"
but he does not elaborate further on the method of production of this
facilitation.
CONCLUSIONS
The neurochemical studies of Feldberg and Vogt'2 have shown that there
exists within the central nervous system a pattern of chemical neuronal
organization consisting of alternating cholinergic and non-cholinergic
neurone pools. This relatively new concept may possibly clarify some ob-
servations upon chemically induced electrocortical activity. It has been
shown that synchronous electrocortical discharges which occur following
strychninization of cerebral cortex are unaffected by atropine or adenine
compounds, whereas these agents inhibit cortical spike potentials caused
by ACh."6 These observations may be partially explained on the basis of
Feldberg's thesis concerning cholinergic and non-cholinergic neurones, in
that the chemical mechanisms involved in inducing synchronous firing fol-
lowing strychninization may include chemical synaptic mediators other than
ACh. Appropriate chemical agents may be necessary for the initiation of
neuronal excitation and discharge depending upon whether the neuronal
pool activated belongs predominantly to cholinergic or non-cholinergic
groups. The ineffectiveness of the adenine nucleotides and atropine in
depressing strychnine-induced electrocortical activity, on the other hand,
may point to some other mechanism of strychnine action as suggested by
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Chang, who believes that this agent decreases the latency of synaptic trans-
mission and increases the chance for synchronous neuronal firing.' It has
also been suggested that strychnine increases oxidative processes in cell
metabolism.6'
Recent contributions from the field of clinical medicine point to the im-
portance of ACh metabolism in cerebral function. The genesis of crypto-
genic epilepsy has been linked to disturbances in ACh metabolism, while
correlations between ChE activity and EEG pattern seem to support this
hypothesis.' ACh has been used to precipitate clinical seizures, whereas
atropine has been shown to afford protection against seizures induced by
such methods. The appearance of ACh in the CSF in appreciable amounts
following severe head injury may be a secondary manifestation of the
altered nucleotide metabolism which has been shown to accompany trauma
to brain tissue.
The arguments upon which the mechanisms of initiation and propagation
of the nerve impulse are based are somewhat weighted toward the con-
sideration that these processes are predominantly if not wholly electrical
in nature. Gerard' has pointed out many discrepancies in the arguments
pointing to importance of ACh, but feels that the long duration of some
synaptic potentials can only be explained on the basis of some chemical
reaction which, however, may be entirely unrelated to ACh metabolism.
Since energy transfer is involved in the production of the electrical mani-
festations of synaptic transmission and nerve conduction, it seems logical
to assume that this energy must be derived from chemical reactions. It is
the purpose of this review to focus attention on those investigations which
have sought to uncover some of the fundamental neurochemical processes
involved in central neural activity.
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